| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 09/01/1992 | US5143713 99m Tc labeled liposomes |
| 09/01/1992 | US5143712 Endothelial leukocyte adhesion molecule-1 blocking agent, antiinflammatory agent |
| 08/26/1992 | CA2037345A1 Endothelial cell-monocyte adhesion molecule |
| 08/25/1992 | US5141648 Methods for isolating compounds using cleavable linker bound matrices |
| 08/25/1992 | CA1306706C Monoclonal antibodies to human gastrointestinal cancer |
| 08/20/1992 | WO1992014150A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | WO1992013952A1 Improved inhibitors of thrombin |
| 08/20/1992 | WO1992013950A2 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 08/20/1992 | WO1992013826A1 Compositions and method for soft tissue tumors |
| 08/20/1992 | WO1992013572A1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |
| 08/20/1992 | WO1992013571A1 Method of treating and/or diagnosing soft tissue tumors |
| 08/20/1992 | WO1992013563A1 Antitumoral preparation and method of making same |
| 08/20/1992 | CA2103893A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/19/1992 | EP0499501A2 New macrocyclic nitrogen ligands, method for their preparation, metal complexes, diagnostic and therapeutic compositions |
| 08/19/1992 | EP0499098A2 Method of treating and/or diagnosing soft tissue tumors |
| 08/19/1992 | CN1063615A Radiopharmaceutical formulations, their method of administration and process of preparation |
| 08/18/1992 | US5140104 Reacting free carboxyl of N-protected, carboxyl-protected glutamic acid with reactive amine, removing N-protecting group, reacting with activated carboxyl group of folic acid derivative, removing all protecting groups |
| 08/18/1992 | CA1306414C Affinity enhancement system |
| 08/15/1992 | WO1992014492A1 In situ synthesis of radiopharmaceuticals |
| 08/15/1992 | CA2101642A1 In situ synthesis of radiopharmaceuticals |
| 08/12/1992 | EP0498771A2 MSH peptide derivatives |
| 08/12/1992 | EP0498470A2 An injectable pharmaceutical composition for the protection of tissue damaged by ischemia |
| 08/12/1992 | EP0498333A2 Preparation of an organospecific substance marked with technetium-99m |
| 08/12/1992 | EP0497926A1 Multi-site metal chelating agents |
| 08/12/1992 | EP0497866A1 Gastrin releasing peptide receptor |
| 08/12/1992 | EP0456766A4 Type oc platelet-derived growth factor receptor gene |
| 08/11/1992 | US5138039 Diagnosis, therapy |
| 08/11/1992 | US5137709 Layered mixed metal hydroxides for the stabilization of radioactive colloids |
| 08/11/1992 | CA1306194C Use of amphipathic molecules for radio-imaging and therapy with conjugates of monoclonal or polyclonal antibodies |
| 08/06/1992 | WO1992012730A1 A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose |
| 08/05/1992 | EP0497356A1 Compositions and method for soft tissue tumors |
| 08/04/1992 | US5135948 Mixture or ascorbic acid and 5,6-benzylideneascorbic acid |
| 08/04/1992 | US5135736 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 08/04/1992 | US5135735 Method of localizing and quantifying regional energy metabolism in a warm-blooded living being and composition therefor |
| 08/04/1992 | CA1305922C Method of myocardial imaging |
| 08/04/1992 | CA1305919C Selecting, compounding and testing antibodies for cancer diagnosis and therapy |
| 07/31/1992 | WO1992013557A1 Stabilized antibody fragments |
| 07/31/1992 | CA2098097A1 Stabilized antibody fragments |
| 07/31/1992 | CA2060332A1 Method of treating and/or diagnosing soft tissue tumors |
| 07/29/1992 | EP0496074A1 Biotinylated monoclonal antibodies, avidin and biotin for diagnosis and therapy |
| 07/28/1992 | US5134075 Antitumor agents |
| 07/28/1992 | US5133956 Radiolabeled metal-binding protein for the treatment of arthritis |
| 07/25/1992 | WO1992012978A1 Novel nitrogenous macrocyclic ligands, their preparation method, polymetallic complexes, and a diagnostic and therapeutical composition |
| 07/25/1992 | CA2078983A1 Nitrogen macrocyclic ligands, preparation method, complex polymetallic diagnostic composition and therapeutical |
| 07/23/1992 | WO1992011846A1 Particulates |
| 07/15/1992 | CN1062735A T-butyloxycarbonyl-l-tyrosyl-peptidoglycan monomer and 125 i-labelled derivative thereof, their preparation and use |
| 07/14/1992 | US5130297 Polypeptides for treatment of arthritis and diabetes |
| 07/14/1992 | US5130129 Method for enhancing antibody transport through capillary barriers |
| 07/14/1992 | US5130118 Radioactive metal ion labelled chelator |
| 07/14/1992 | US5130117 Radiohalogenated benzazepine derivatives and method of imaging dopamine receptors therewith |
| 07/14/1992 | US5130116 Radiotherapeutic immunoconjugates labeled with iodine-125 |
| 07/14/1992 | CA1305160C Ether isonitriles and radiolabeled complexes thereof |
| 07/09/1992 | WO1992011039A1 Derivatized tris-catechol chelating agents |
| 07/09/1992 | WO1992011033A1 Control of gene expression by ionizing radiation |
| 07/09/1992 | WO1992011032A1 Radionuclide labelled particles useful for radiation synovectomy |
| 07/09/1992 | CA2097927A1 Radionuclide labelled particles useful for radiation synovectomy |
| 07/08/1992 | EP0493526A1 Stable therapeutic radionuclide compositions and methods for preparation thereof |
| 07/07/1992 | US5128119 Methods for technetium/rhenium labeling of f(ab1)2 fragments |
| 07/07/1992 | US5128118 Cocaine receptor binding ligands |
| 07/01/1992 | EP0492478A2 Tert-butyloxycarbonyl-L-tyrosyl-peptidoglycan monomer and 125 I-labelled derivative thereof, their preparation and use |
| 07/01/1992 | EP0438527A4 Radiolabelled particulate composition |
| 06/30/1992 | US5126122 Preferential bonding to tumor |
| 06/30/1992 | CA1304364C Radioactive benzodiazepine derivative and processes for producing the same |
| 06/25/1992 | WO1992010214A1 Method of radioactive labelling of blood cells and kit therefor |
| 06/24/1992 | EP0396617B1 Paramagnetic compounds |
| 06/23/1992 | US5124471 Radiolabeling proteins |
| 06/22/1992 | WO1992011040A2 99mTc(III) MYOCARDIAL IMAGING AGENTS AND METHOD OF USE |
| 06/22/1992 | CA2097081A1 Tc(iii)myocardial imaging agents and method of use |
| 06/22/1992 | CA2058247A1 Tert-butyloxcarbonyl-1-tyrosyl-peptidoglycan monomer and 1251-labelled derivative thereof, their preparation and use |
| 06/17/1992 | EP0490434A1 Labelled, modified oligonucleotides |
| 06/17/1992 | EP0185680B1 Steroidal liposomes |
| 06/16/1992 | US5122363 Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract |
| 06/16/1992 | US5122361 2-Pyrrolidinylmethylcarboxamido-2,3-dihydrobenzofuran type compounds |
| 06/16/1992 | CA1303505C Anti-tumor compositions containing 5, 5-dimethyl-2- phenyl-4-thiazolidine carboxylic acid or 5, 5- dimethyl-2-(2-hydroxyphenyl)-4-thiazolidine carboxylic acid |
| 06/15/1992 | WO1992010466A1 Hexadentate ligands useful in radiographic imaging agents |
| 06/15/1992 | WO1992010465A1 Novel preorganized hexadentate ligands useful in radiographic imaging agents |
| 06/15/1992 | CA2076024A1 Preorganized hexadentate ligands useful in radiographic imaging agents |
| 06/15/1992 | CA2076016A1 Hexadentate ligands useful in radiographic imaging agents |
| 06/11/1992 | WO1992009701A1 Analytical tracers for cancer, particularly malignant breast cancer |
| 06/11/1992 | WO1992009610A1 Drug delivery porphyrin compositions and methods |
| 06/11/1992 | WO1992009282A1 Treatment for tissue ulceration |
| 06/11/1992 | CA2073860A1 Analytical tracers for cancer, particularly malignant breast cancer |
| 06/11/1992 | CA2057292A1 Labelled, modified oligonucleotides |
| 06/10/1992 | EP0489061A1 Radio-labelled antibodies for imaging |
| 06/10/1992 | EP0310645B1 Compounds useful particularly for radiotherapy or imaging of cancer |
| 06/09/1992 | US5120537 Factor X or fragment thereof having little or no serine esterase activity, which is capable of binding with factor V in the blood of a mammal, and a carrier |
| 06/09/1992 | US5120526 Method of producing metal radionuclide labeled proteins for diagnosis and therapy |
| 06/09/1992 | US5120525 Radiolabeled antibody cytotoxic therapy of cancer |
| 06/08/1992 | WO1992010213A1 Molecular sieve-enclosed paramagnetic ion for diagnosis |
| 06/03/1992 | EP0467954A4 Preparation of liposome and lipid complex compositions |
| 06/02/1992 | US5118798 Neogalactoalbumin or galactose-bonded polylysine chemically bonded to a chelate-forming compound and radioactive metal |
| 06/02/1992 | US5118499 For topical treatment of rheumatoid arthritis and cancer |
| 06/02/1992 | US5117830 Method of determining viability of tissue |
| 06/02/1992 | CA1302403C Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor |
| 05/29/1992 | WO1992008725A1 Polyazamacrocyclic compounds for complexation of metal ions |
| 05/29/1992 | WO1992008497A1 In vivo brain imaging agent and method for diagnosis of psychiatric disorders |
| 05/29/1992 | WO1992008494A2 Targeting radioactive immunoreagents |
| 05/29/1992 | WO1992008489A1 Treatment for inflammatory bowel disease |
| 05/29/1992 | WO1992005866A3 Efficient microcapsule preparation and method of use |
| 05/27/1992 | EP0486622A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |